Onset of recession may take longer than expected after yield curve inverts
December 10, 2018
Stock selloff snowballs on fresh fears for world growth
December 10, 2018

Gilead Sciences snares Roche veteran O’Day as CEO

Drugmaker Gilead Sciences Inc on Monday named Roche Holding AG’s Daniel O’Day as its new chief executive, tapping an industry veteran to fill a management vacuum.

Powered by WPeMatico